Gastrointestinal Cancers Hub

Gastrointestinal Cancers Hub

Videos

b2ap3_large_ODA-Expert-Perspectives-Esophageal-Cancer-Awareness-Month_960x800
b2ap3_large_Video-Expert-Perspectives-Rosen-and-Hadfield_960x800
b2ap3_large_Video-Expert-Perspectives-Gallbladder-Cancer-Awareness_960x80_20240215-171610_1
For Pancreatic Cancer Awareness Month, Joseph Kalis, PharmD, explains challenges and ongoing research in pancreatic cancer.
In honor of Appendix Cancer Awareness Month, Dr. Thomas Abrams explains the subtypes and treatments for the disease.
At ASCO 2023, Allison Rosen shares the story of her cancer journey and how she became involved in patient advocacy.

News

b2ap3_large_Atypical_carcinoid_tumor-compressed
b2ap3_large_Adenocarcinoma_of_Pancreas_FNA_5558642382-compressed
The FDA has amended the existing indication of pembrolizumab for the first-line treatment of HER2-positive gastric cancers.
The FDA approved fruquintinib for adult patients with metastatic colorectal cancer (mCRC).
i3 Health provided an educational activity that challenged knowledge gaps for precision medicine in BRAF V600E­–mutant metastatic CRC.
The FDA has granted accelerated approval to tucatinib in combination with trastuzumab for metastatic colorectal cancer.

Podcasts

b2ap3_large_Podcast-Expert-Perspectives-208CRC-Bonus-Content_960x800-1
Sepideh Gholami discusses hepatic artery infusion pumps, its benefits, and how it will affect the future treatment landscape of cancer.
For Pancreatic Cancer Awareness Month, Joseph Kalis, PharmD, explains challenges and ongoing research in pancreatic cancer.
In honor of Appendix Cancer Awareness Month, Dr. Thomas Abrams explains the subtypes and treatments for the disease.
Dr. Kohei Shitara discusses the efficacy of zolbetuximab for gastric/gastroesophageal junction adenocarcinoma.
Dr. Shubham Pant shares ASCO results of the HERIZON-BTC-01 trial of zanidatamab in biliary tract cancers.